BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21897119)

  • 1. Overexpression of VEGF189 in breast cancer cells induces apoptosis via NRP1 under stress conditions.
    Vintonenko N; Pelaez-Garavito I; Buteau-Lozano H; Toullec A; Lidereau R; Perret GY; Bieche I; Perrot-Applanat M
    Cell Adh Migr; 2011; 5(4):332-43. PubMed ID: 21897119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels.
    Hervé MA; Buteau-Lozano H; Vassy R; Bieche I; Velasco G; Pla M; Perret G; Mourah S; Perrot-Applanat M
    Am J Pathol; 2008 Jan; 172(1):167-78. PubMed ID: 18079435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDA-MB-231 breast cancer cells overexpressing single VEGF isoforms display distinct colonisation characteristics.
    Di Benedetto M; Toullec A; Buteau-Lozano H; Abdelkarim M; Vacher S; Velasco G; Christofari M; Pocard M; Bieche I; Perrot-Applanat M
    Br J Cancer; 2015 Sep; 113(5):773-85. PubMed ID: 26196186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF189 binds NRP1 and is sufficient for VEGF/NRP1-dependent neuronal patterning in the developing brain.
    Tillo M; Erskine L; Cariboni A; Fantin A; Joyce A; Denti L; Ruhrberg C
    Development; 2015 Jan; 142(2):314-9. PubMed ID: 25519242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long isoform of VEGF stimulates cell migration of breast cancer by filopodia formation via NRP1/ARHGAP17/Cdc42 regulatory network.
    Kiso M; Tanaka S; Saji S; Toi M; Sato F
    Int J Cancer; 2018 Dec; 143(11):2905-2918. PubMed ID: 29971782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of neuropilin-1 by RNA-interference and its angiostatic potential in the treatment of hepatocellular carcinoma.
    Raskopf E; Vogt A; Standop J; Sauerbruch T; Schmitz V
    Z Gastroenterol; 2010 Jan; 48(1):21-7. PubMed ID: 20072992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1.
    Lee TH; Seng S; Sekine M; Hinton C; Fu Y; Avraham HK; Avraham S
    PLoS Med; 2007 Jun; 4(6):e186. PubMed ID: 17550303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF-A/Neuropilin 1 Pathway Confers Cancer Stemness via Activating Wnt/β-Catenin Axis in Breast Cancer Cells.
    Zhang L; Wang H; Li C; Zhao Y; Wu L; Du X; Han Z
    Cell Physiol Biochem; 2017; 44(3):1251-1262. PubMed ID: 29179185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
    Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES
    Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells.
    Zhang S; Zhau HE; Osunkoya AO; Iqbal S; Yang X; Fan S; Chen Z; Wang R; Marshall FF; Chung LW; Wu D
    Mol Cancer; 2010 Jan; 9():9. PubMed ID: 20085644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity.
    Glinka Y; Prud'homme GJ
    J Leukoc Biol; 2008 Jul; 84(1):302-10. PubMed ID: 18436584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cells.
    Shen HL; Xu W; Wu ZY; Zhou LL; Qin RJ; Tang HR
    Leuk Res; 2007 Apr; 31(4):515-21. PubMed ID: 17034851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
    Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
    Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of two novel alternatively spliced Neuropilin-1 isoforms.
    Cackowski FC; Xu L; Hu B; Cheng SY
    Genomics; 2004 Jul; 84(1):82-94. PubMed ID: 15203206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of VEGF183 promotes murine breast cancer cell proliferation in vitro and induces dilated intratumoral microvessels.
    Zhang H; Chen Y; Fan B; Wang W; Zhu W
    Tumour Biol; 2015 May; 36(5):3871-80. PubMed ID: 25577246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding.
    Soker S; Miao HQ; Nomi M; Takashima S; Klagsbrun M
    J Cell Biochem; 2002; 85(2):357-68. PubMed ID: 11948691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gain of affinity for VEGF165 binding within the VEGFR2/NRP1 cellular complex detected by an HTRF-based binding assay.
    Auriau J; Roujeau C; Belaid Choucair Z; Oishi A; Derviaux C; Roux T; Trinquet E; Hermine O; Jockers R; Dam J
    Biochem Pharmacol; 2018 Dec; 158():45-59. PubMed ID: 30236477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropilin-1 is involved in regulation of apoptosis and migration of human colon cancer.
    Ochiumi T; Kitadai Y; Tanaka S; Akagi M; Yoshihara M; Chayama K
    Int J Oncol; 2006 Jul; 29(1):105-16. PubMed ID: 16773190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low molecular weight fucoidan increases VEGF165-induced endothelial cell migration by enhancing VEGF165 binding to VEGFR-2 and NRP1.
    Lake AC; Vassy R; Di Benedetto M; Lavigne D; Le Visage C; Perret GY; Letourneur D
    J Biol Chem; 2006 Dec; 281(49):37844-52. PubMed ID: 17028197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.
    Hu B; Guo P; Bar-Joseph I; Imanishi Y; Jarzynka MJ; Bogler O; Mikkelsen T; Hirose T; Nishikawa R; Cheng SY
    Oncogene; 2007 Aug; 26(38):5577-86. PubMed ID: 17369861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.